✦ LIBER ✦

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis

✍ Scribed by Gill, D R; Southern, K W; Mofford, K A; Seddon, T; Huang, L; Sorgi, F; Thomson, A; MacVinish, L J; Ratcliff, R; Bilton, D

Book ID: 110037992
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 526 KB
Volume: 4
Category: Article
ISSN: 0969-7128
DOI: 10.1038/sj.gt.3300391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liposome-mediated CFTR gene transfer to

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

✍ Caplen, Natasha J.; Alton, Eric W.F.W.; Mddleton, Peter G.; Dorin, Julia R.; Ste 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 923 KB

Evidence for safety and efficacy of DOTA

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

✍ Porteous, D J; Dorin, J R; McLachlan, G; Davidson-Smith, H; Davidson, H; Stevens 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 867 KB

Repeat administration of DNA/liposomes t

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

✍ Hyde, S C; Southern, K W; Gileadi, U; Fitzjohn, E M; Mofford, K A; Waddell, B E; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB

Lentivirus-mediated gene transfer to the

Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis

✍ Copreni, E; Penzo, M; Carrabino, S; Conese, M 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

Patch application of the dopamine agonis

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double-blind, placebo-controlled pilot study

✍ Karin Stiasny-Kolster; Ralf Kohnen; Erwin Schollmayer; J. Carsten Möller; Wolfga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract Efficacy and safety of the dopamine agonist rotigotine (RTG) was investigated in patients with moderate to severe idiopathic restless legs syndrome (RLS), including daytime symptoms. Three fixed doses of rotigotine (1.125 mg, 2.25 mg, and 4.5 mg) and placebo were applied by patches (siz

Pilot study for the evaluation of T-cell

Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors

✍ R. Mertelsmann; A. Lindemann; T. Boehm; U. Brennscheidt; B. Franke; P. Kulmburg; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 157 KB